Recent Studies on Oxytocin as a Therapy for Autism
Researchers at Emery University have just published a study in Neuropsychopharmacology on the use of Oxytocin as a therapy to enhance social function in psychiatric disorders, including autism spectrum disorders and schizophrenia. The full article can be found here: http://bit.ly/1G1VWm3.
Tergus worked with researchers at the University of North Carolina School of Medicine to do testing, scale-up and research supply manufacturing of an intra-nasally administered Oxytocin for a clinical study involving children with Autism. This is an exciting research area and we were very honored to work with Dr. Linmarie Sikich of UNCs ASPIRE program.
If you would like a copy of the case study, please contact us.
- Tergus Pharma Announces New Commercial Manufacturing Facility and Partnership with Great Point Partners
- Skin Cancer Drug Fast-tracked to Patients in UK
- BioPharma Reporter Analysis of Biosimilars
- Recent Studies on Oxytocin as a Therapy for Autism
- Tergus at the 6th AGAH Dermatology Product Development Workshop
- The View from the Floor of the World Congress of Dermatology Conference